Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Interrater and Intrarater Reliability of the Vertebral Bone Quality Score.

World neurosurgery·2021

Same author

Removal of instrumentation for postoperative spine infection: systematic review.

Journal of neurosurgery. Spine·2021

Same author

Are Lumbar Fusion Guidelines Followed? A Survey of North American Spine Surgeons.

Neurospine·2021

Same author

Impact of Multidisciplinary Intraoperative Teams on Thirty-Day Complications After Sacral Tumor Resection.

World neurosurgery·2021

Same author

Surgical Stabilization for Patients with Mechanical Back Pain Secondary to Metastatic Spinal Disease is Associated with Improved Objective Mobility Metrics: Preliminary Analysis in a Cohort of 26 Patients.

World neurosurgery·2021

Same author

Racial Disparities in Perioperative Morbidity Following Oncological Spine Surgery.

Global spine journal·2021

Search research articles

Related Experiment Video

Updated: Dec 26, 2025

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

Hybrid Therapy for Spinal Metastases.

Robert Rothrock¹, Zach Pennington², Jeff Ehresman²

¹Department of Neurosurgery, Mount Sinai Hospital, New York, NY, USA.

Neurosurgery Clinics of North America

|March 10, 2020

Summary

This summary is machine-generated.

Hybrid therapy combining separation surgery and stereotactic body radiotherapy (SBRT) offers optimal treatment for metastatic spine tumors, improving local control and patient outcomes.

Keywords:

Hybrid therapy Metastases Radiation Radiosurgery Separation surgery Spinal cord Spine Tumor

More Related Videos

Surgical Transplantation of Tumor Cells into the Spinal Cord of Mice

Surgical Transplantation of Tumor Cells into the Spinal Cord of Mice

Published on: December 27, 2024

Related Experiment Videos

Last Updated: Dec 26, 2025

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

Surgical Transplantation of Tumor Cells into the Spinal Cord of Mice

Surgical Transplantation of Tumor Cells into the Spinal Cord of Mice

Published on: December 27, 2024

Area of Science:

Oncology
Neurosurgery
Radiation Oncology

Background:

Metastatic spine tumors pose significant treatment challenges.
Traditional surgical approaches may have limitations in achieving durable local control.
Stereotactic body radiotherapy (SBRT) has emerged as a potent tool in cancer treatment.

Purpose of the Study:

To evaluate the efficacy and safety of hybrid therapy for metastatic spine tumors.
To assess the role of SBRT in conjunction with surgical decompression and stabilization.
To compare outcomes of hybrid therapy with traditional treatment modalities.

Main Methods:

Hybrid therapy involves separation surgery for spinal cord decompression and stabilization.
Ablative SBRT is delivered to the tumor following surgical intervention.
Patient tolerance, systemic therapy return, and local tumor control are assessed.

Main Results:

Hybrid therapy demonstrates superb local control rates for metastatic spine tumors.
The approach is well-tolerated by patients.
Early return to systemic therapy is facilitated, and durable tumor control is achieved.

Conclusions:

Hybrid therapy optimizes metastatic spine tumor treatment by integrating surgery and SBRT.
This approach enhances local tumor control and patient recovery compared to traditional methods.
SBRT plays an increasingly important adjuvant role in managing spinal metastases.